Enlargement of price limit benefited pharmaceutical stocks, increasing 20% in a favorable condition

Since the 15^th of this month, enlargement of price limit from 15% to 30% has benefited stock price of pharmaceutical companies.

Although an opinion was raised that the spread of MERS might stop the uptrend of pharmaceutical stocks, the new drug development expectation has continued the trend.

On the 25^th, 10 pharmaceutical stocks in the stock market have made over 15% increases compared to th...